News

Sarepta’s Risky Gamble: Gene Therapy Stays on Market Despite FDA Request
When three patients die after taking a cutting-edge drug, most companies hit the brakes. Not Sarepta Therapeutics. The ...
Gene therapy maker Sarepta tells FDA it won’t halt shipments despite patient deaths
Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene ...
WCMH Columbus on MSN19h
Sarepta Therapeutics lays off 500 employees amid FDA investigation, including 80 in Columbus
Sarepta Therapeutics announced it is laying off nearly 500 employees this week, including 80 at its Easton location. According to a mass layoff notice filed with the ...
Health and Me on MSN6h
"Obsolete And Unnecessary": FDA Set To Revoke 52 Nutrition And Labeling Rules
The FDA plans to revoke 52 outdated nutrition and labeling regulations to streamline food industry standards, citing them as ...
vornews13h
Sarepta Tells FDA It Won’t Stop Shipments Despite Patient Deaths
Sarepta Therapeutics announced late Friday evening that it will not comply with the Food and Drug Administration's ...
National Law Review8h
FDA Calls on Infant and Children’s Food Brands to Improve Recall Communications
FDA outlines both short-term and long-term goals within the letter. In the short term, FDA plans to create a “centralized, ...
National Law Review9h
FDA Commissioner Marks His First 100 Days
FDA published a press release written by FDA Commissioner Marty Makary that highlighted his efforts to “make food healthier for children and families, accelerate meaningful cures and treatments, and ...